Le Lézard
Classified in: Health
Subjects: EXE, AVO

Blue Cross Blue Shield Of Massachusetts Releases Statement On Trump Administration's Recent Actions Related To Health Care


BOSTON, Oct. 13, 2017 /PRNewswire-USNewswire/ -- In response to recent health care actions announced by the Trump administration, Andrew Dreyfus, President & CEO of Blue Cross Blue Shield of Massachusetts, released the following statement:

Blue Cross Blue Shield of Massachusetts

"We are deeply concerned that the Administration's recent actions will create further instability in the insurance market and threaten our shared goal of providing affordable and quality coverage and care to everyone, regardless of economic status, age, or condition.

At Blue Cross and Blue Shield of Massachusetts, our highest priority is ensuring that quality health coverage is accessible and affordable for our members, employer customers, and the community. The measures proposed by the Administration would likely create an unfair and unstable market, making coverage out of reach for those who need it most and undermining the meaningful progress that our state and nation have made in extending health insurance coverage to our fellow citizens.

We encourage policy makers to work in a bipartisan spirit to improve the Affordable Care Act to create a health care system that is high quality, affordable, and sustainable."

About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts (bluecrossma.com) is a community-focused, tax-paying, not?for?profit health plan headquartered in Boston. We're the trusted health plan for more than 25,000 Massachusetts employers and are committed to working with others in a spirit of shared responsibility to make quality health care affordable. Consistent with our corporate promise to always put our 2.9 million members first, we're rated among the nation's best health plans for member satisfaction and quality. Connect with us on FacebookTwitterYouTube, and LinkedIn.

 

SOURCE Blue Cross Blue Shield of Massachusetts


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: